Pat-INFORMED – The Gateway to Medicine Patent Information
Pat-INFORMED, a private-public partnership between the World Intellectual Property Organisation, the...
Back to List
Eli Lilly and Company
Lilly 30x30 is the company's goal to create new access to quality health care for 30 million people in resource-limited settings by the year 2030. To reach that goal, we have to find new solutions across our business and with our partners.
COLLABORATIONS
SHOWING 5 of 19 COLLABORATIONS
See All
Access Accelerated Initiative
Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...
Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Pharma, Takeda Pharmaceutical Company Limited, UCB
TransCelerate Biopharma
TransCelerate is a nonprofit organization with the mission to collaborate across the biopharmaceutical...
AbbVie, Astellas Pharma Inc, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Pfizer Inc, Sanofi, UCB
TB Drug Accelerator Program
Aiming to speed up the discovery and development of novel compounds against tuberculosis (TB)....
AbbVie, AstraZeneca, Bayer AG, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, MSD
TB Drug Discovery Initiative
Accelerating early-stage drug discovery for potential new treatments for TB....
Eli Lilly and Company, MSD
SHOWING 5 of 19 COLLABORATIONS
See All